amfAR, The Foundation for AIDS Research

Community and Policy

Community

A founding principle of TREAT Asia is that the effective delivery of antiretrovirals across Asia requires the active participation of civil society, including individuals and organizations representing people living with HIV/AIDS. TREAT Asia seeks to strengthen the understanding of treatment among Asia’s most affected communities, endowing them with the tools to empower and educate patients on local, regional, and national levels.

Taking Discrimination to Court in India

Policy Brief: Sexual and Reproductive Health of HIV-Positive Women in Asia

TREAT Asia's 14th Annual Network Meeting

Online HIV Awareness Campaign Debuts in Malaysia

New Data on HIV/AIDS in Asia

Investigator Profile: Dr. Jintanat Ananworanich’s Search for the Cure

WHO Releases First International Hepatitis C Treatment Guidelines

Merck Cuts the Price of Hepatitis C Drug

Policy Brief: Hepatitis C and HIV – Addressing the Dual Epidemic

Celebs Tweet for HIV Awareness in Indonesia

WikiLeaks Reveals How the TPP Could Limit Treatment Access across the Asia-Pacific

New Report Calls for Better HIV Care for Adolescents in Asia

Organ Transplantation and HIV: New Hope for Policy Reform?

The World Bank Invests in Ending AIDS - The TREAT Asia Report interview: Dr. Jim Kim

TAHOD Turns Ten

New Agreement Could Facilitate Production of a Generic Oral CMV Treatment

Indian Supreme Court Ruling Preserves Access to Low-Cost Drugs

Preventing forced Abortion and Sterilization

A New Celebrity-Focused HIV Campaign Hits Indonesia

amfAR Mourns the Loss of Pioneering Activist Shivananda Khan

Insight: Policy Developments In Asia And The Pacific

Good News, Bad News in UNAIDS Report

An Interview with Françoise Barré-Sinoussi, Ph.D.— Pushing for Better Coordination on Cure ResearchAIDS Takes Center Stage in Washington

Effecting Change: Service Organizations as Community Advocates

Rebooting the Response to AIDS in the Asia-Pacific

In Pursuit of an “AIDS-Free Generation”

Hepatitis C: National Governments Need to Respond  

Access to Affordable HIV Medicines at Risk in Trade Negotiations